Randomized controlled study on combination therapy of tiotropium bromide and sustained-release theophyline for moderate stable COPD.
Phase of Trial: Phase IV
Latest Information Update: 21 May 2012
At a glance
- Drugs Tiotropium bromide (Primary) ; Theophylline
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Planned end date 31 Jan 2009 added as reported by Chinese Clinical Trial Register.
- 26 Nov 2011 New trial record